Comerica Bank’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-53,380
| Closed | -$213K | – | 2327 |
|
|
2019
Q4 | $213K | Sell |
53,380
-50
| -0.1% | -$235 | ﹤0.01% | 2177 |
|
|
2019
Q3 | $277K | Buy |
53,430
+1,019
| +2% | +$5.7K | ﹤0.01% | 2088 |
|
|
2019
Q2 | $281K | Sell |
52,411
-3,757
| -7% | -$20K | ﹤0.01% | 2089 |
|
|
2019
Q1 | $322K | Buy |
56,168
+1,609
| +3% | +$16.6K | ﹤0.01% | 2034 |
|
|
2018
Q4 | $725K | Sell |
54,559
-240
| -0.4% | -$4.05K | 0.01% | 1716 |
|
|
2018
Q3 | $1.14M | Buy |
54,799
+3,652
| +7% | +$77.8K | 0.01% | 1516 |
|
|
2018
Q2 | $1.32M | Sell |
51,147
-1,930
| -4% | -$45K | 0.01% | 1519 |
|
|
2018
Q1 | $1.12M | Buy |
53,077
+1,281
| +2% | +$29.9K | 0.01% | 1580 |
|
|
2017
Q4 | $1.34M | Buy |
51,796
+1,321
| +3% | +$26K | 0.01% | 1496 |
|
|
2017
Q3 | $1.05M | Buy |
50,475
+4,524
| +10% | +$76.5K | 0.01% | 1598 |
|
|
2017
Q2 | $711K | Sell |
45,951
-2,296
| -5% | -$38.3K | 0.01% | 1713 |
|
|
2017
Q1 | $742K | Buy |
48,247
+2,117
| +5% | +$30.5K | 0.01% | 1735 |
|
|
2016
Q4 | $649K | Buy |
46,130
+1,293
| +3% | +$24.1K | 0.01% | 1761 |
|
|
2016
Q3 | $1.26M | Buy |
44,837
+7,171
| +19% | +$241K | 0.01% | 1377 |
|
|
2016
Q2 | $1.39M | Buy |
+37,666
| New | +$1.18M | 0.01% | 1310 |
|
Other funds holding DPLO
Comerica Bank's DPLO Position: Q1 2020 in Review
Comerica Bank sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 53,380 shares — an estimated $213K sold.
Comerica Bank first reported a position in DPLO in Q2 2016 and held it in 15 quarters. The position peaked at $1.39M in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Comerica Bank reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Comerica Bank sold 53,380 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $213K.
- Comerica Bank first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 15 quarters.
- Comerica Bank's DIPLOMAT PHARMACY, INC. position peaked at $1.39M in Q2 2016.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Comerica Bank's 13F filing for Q1 2020, filed 1 May 2020.